TIOVA SYNCHROBREATHE (Tiotropium (9mcg))

TIOVA SYNCHROBREATHE INHALER contains the active ingredient Tiotropium bromide, classified as a bronchodilator. This medication is primarily prescribed for the ongoing management of chronic obstructive pulmonary disease (COPD), a respiratory condition marked by persistent airflow limitation that is not entirely reversible. Patients suffering from COPD typically experience chronic cough and sputum production. Prior to initiating treatment with TIOVA SYNCHROBREATHE INHALER, it is essential for healthcare providers to conduct a thorough assessment including various diagnostic tests to evaluate the patient’s current health status. It is crucial to inform your healthcare provider about any pre-existing kidney issues, a history of heart attack within the past six months, or any episodes of unstable or life-threatening cardiac arrhythmias. Additionally, individuals with severe heart failure in the last year or those experiencing urinary retention should also provide this information. Patients with conditions such as narrow-angle glaucoma or a history of sudden breathing difficulties must exercise caution as well. Use of this inhaler in pregnant or breastfeeding women should only occur under medical supervision. This medication is not intended for individuals under 18 years of age, and consultation with a healthcare professional is recommended before use. The most frequently reported side effect associated with TIOVA SYNCHROBREATHE INHALER is dry mouth. Patients should remain vigilant and report any worsening of side effects to their physician.